{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:29:59Z","timestamp":1791304199730,"version":"4.3.1"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Childhood Sjogren's syndrome (cSS) is a rare, chronic autoimmune disease characterized by inflammation of the exocrine glands. cSS is underrecognized because of differences in clinical presentation compared with adults. Until recently, publications describing clinical manifestations in cSS were limited to case reports and case series with small numbers of patients. Diagnostic studies to assess glandular symptoms in adults, are less commonly obtained in children.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Recent cohort studies describe presenting diagnostic clinical features in large populations of cSS and demonstrate how current classification criteria, used in adults, are not applicable to children. Recurrent parotitis is the consistent predominant manifestation that is inversely correlated with age. Novel salivary biomarkers and salivary gland ultrasonography are important objective measure, which may improve diagnosis and disease monitoring. Standardized treatment recommendations are needed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Findings from large cohort studies provide a framework for the future development of diagnostic criteria for cSS. Such criteria should incorporate objective measures that are easily obtained in children. Future research to improve understanding of the application of novel biomarkers and imaging and developing consensus on treatment recommendations is needed.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mop.0000000000001093","type":"journal-article","created":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T16:00:30Z","timestamp":1638979230000},"page":"217-222","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Updates in childhood Sjogren's syndrome"],"prefix":"10.1097","volume":"34","author":[{"given":"Tracey B.","family":"Wright","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,12,7]]},"reference":[{"key":"R1-20250730","first-page":"343","article-title":"Features of childhood Sjogren's syndrome in comparison to adult Sjogren's syndrome: considerations in establishing child-specific diagnostic criteria","volume":"34","author":"Yokogawa","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"R2-20250730","doi-asserted-by":"crossref","first-page":"e2020042127","DOI":"10.1542\/peds.2020-042127","article-title":"Childhood-onset Sjogren syndrome presenting as pulmonary hemorrhage","volume":"148","author":"Wang","year":"2021","journal-title":"Pediatrics"},{"key":"R3-20250730","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12969-020-0412-8","article-title":"Adolescent Sjogren's syndrome presenting as psychosis: a case series","volume":"18","author":"Hammett","year":"2020","journal-title":"Pediatr Rheumatol J"},{"key":"R4-20250730","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/nrneph.2015.174","article-title":"Renal involvement in primary Sjogren syndrome","volume":"12","author":"Francois","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"R5-20250730","first-page":"123","article-title":"Renal involvement in primary Sjogren's syndrome: natural history and treatment outcome","volume":"37 Suppl 118","author":"Goules","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"R6-20250730","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12969-020-00431-y","article-title":"Nephrological disorders and neurological involvement in pediatric primary Sjogren syndrome:a case report and review of literature","volume":"18","author":"Zhao","year":"2020","journal-title":"Pediatr Rheumatol Online J"},{"key":"R7-20250730","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"R8-20250730","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/acr.21591","article-title":"American College of Rheumatology classification criteria for Sjogren's syndrome: a data-driven, expert consensus approach in the Sjogren's International Collaborative Clinical Alliance cohort","volume":"64","author":"Shiboski","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R9-20250730","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sjogren's syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"76","author":"Shiboski","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R10-20250730","first-page":"381","article-title":"Primary Sjogren's syndrome in children and adolescents: proposal for diagnostic criteria","volume":"17","author":"Bartunkova","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"R11-20250730","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1093\/rheumatology\/keab032","article-title":"Childhood-onset of primary Sjogren's syndrome: phenotypic characterization at diagnosis of 158 children","volume":"60","author":"Ramos-Casals","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"R12-20250730","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1093\/rheumatology\/keaa757","article-title":"Childhood Sjogren syndrome: features of an international cohort and application of the 2016\u200aACR\/EULAR classification criteria","volume":"60","author":"Basiaga","year":"2021","journal-title":"Rheumatology (Oxford, England)"},{"key":"R13-20250730","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.semarthrit.2020.11.004","article-title":"Childhood Sjogren's syndrome: an Italian case series and a literature review-based cohort","volume":"51","author":"Marino","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"R14-20250730","doi-asserted-by":"crossref","first-page":"704193","DOI":"10.3389\/fimmu.2021.704193","article-title":"The diagnostic performance of early sjogren's syndrome autoantibodies in juvenile Sjogren's syndrome: the University of Florida Pediatric Cohort Study","volume":"12","author":"Thatayatikom","year":"2021","journal-title":"Front Immunol"},{"key":"R15-20250730","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keab098","article-title":"A distinguishing profile of chemokines, cytokines, and biomarkers in the saliva of children with Sjogren's syndrome","author":"Gomez Hernandez","year":"2021","journal-title":"Rheumatology (Oxford, England)"},{"key":"R16-20250730","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/art.39015","article-title":"High fidelity between saliva proteomics and the biologic state of salivary glands defines biomarker signatures for primary Sjogren's syndrome","volume":"67","author":"Delaleu","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R17-20250730","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/acr.23839","article-title":"Juvenile Sjogren's syndrome: clinical characteristics with focus on salivary gland ultrasonography","volume":"72","author":"Hammenfors","year":"2020","journal-title":"Arthritis Care Res"},{"key":"R18-20250730","article-title":"Comparison of salivary gland MRI and ultrasonography findings among patients with Sjogren's syndrome over a wide age range","author":"Takagi","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"R19-20250730","article-title":"Treatment strategies for Sjogren's syndrome with childhood onset: a systematic review of the literature","author":"Doolan","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"R20-20250730","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/art.40395","article-title":"The childhood arthritis and rheumatology research alliance consensus treatment plans: toward comparative effectiveness in the pediatric rheumatic diseases","volume":"70","author":"Ringold","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"R21-20250730","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1093\/rheumatology\/kex375","article-title":"The British Society for Rheumatology guideline for the management of adults with primary Sjogren's syndrome","volume":"56","author":"Price","year":"2017","journal-title":"Rheumatology"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001093","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T18:10:19Z","timestamp":1753899019000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,7]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000001093","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,7]]}}}